Percutaneous mitral balloon valvuloplasty reduces mean platelet volume in patients with rheumatic mitral stenosis

References

• Lancé MD, van Oerle R, Henskens YM, Marcus MA. Do we need time adjusted mean platelet volume measurements? Lab Hematol 2010;16:28–31.
   PubMedGoogle Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9: 177–90.
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002;13:301–6.
   PubMed Web of Science ®Google Scholar
• Sharma G, Berger JS. Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data. J Thromb Thrombolysis 2011;32:201–8.
   PubMed Web of Science ®Google Scholar
• D'Erasmo E, Aliberti G, Celi FS, Romagnoli E, Vecci E, Mazzuoli GF. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. J Intern Med 1990;227:11–4.
   PubMed Web of Science ®Google Scholar
• Salem DN, O'Gara PT, Madias C, Pauker SG; American College of Chest Physicians. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest 2008;133:593S–629S.
   Web of Science ®Google Scholar
• Chen MC, Chang HW, Juang SS, Yip HK, Wu CJ. Increased plasma levels of soluble P-selectin in rheumatic mitral stenosis. Chest 2004;126:54–8.
   PubMed Web of Science ®Google Scholar
• Chen MC, Chang HW, Wu CJ, Yang CH, Hung WC, Yeh KH, Fu M. Percutaneous transluminal mitral valvuloplasty reduces circulating soluble CD40 ligand in rheumatic mitral stenosis. Chest 2005;128:36–41.
   PubMedGoogle Scholar
• Chen MC, Wu CJ, Yip HK, Chang HW, Fang CY, Yu TH, Fu M. Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P- selectin expression by flow cytometry. Chest 2003;124: 1663–9.
   PubMedGoogle Scholar
• Varol E, Ozaydin M, Turker Y, Alaca S. Mean platelet volume, an indicator of platelet activation, is increased in patients with mitral stenosis and sinus rhythm. Scand J Clin Lab Invest 2009;69:708–12.
   PubMed Web of Science ®Google Scholar
• Chen MC, Wu CJ, Chang HW, Yip HK, Chen YH, Cheng CI, Chai HT. Mechanism of reducing platelet activity by percutaneous transluminal mitral valvuloplasty in patients with rheumatic mitral stenosis. Chest 2004;125: 1629–34.
   PubMedGoogle Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79–108.
   PubMed Web of Science ®Google Scholar
• Inoue K. Percutaneous transvenous mitral commissurotomy using the Inoue balloon. Eur Heart J 199;12(Suppl. B):99–108.
   Google Scholar
• Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010;8:148–56.
   PubMed Web of Science ®Google Scholar
• Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001;22:1561–71.
   PubMed Web of Science ®Google Scholar
• Karpatkin S, Khan Q, Freedman M. Heterogeneity of platelet function. Correlation with platelet volume. Am J Med 1978; 64:542–6.
   Google Scholar
• Jakubowski JA, Adler B, Thompson CB, Valeri CR, Deykin D. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med 1985;105:271–6.
   PubMed Web of Science ®Google Scholar
• Erne P, Wardle J, Sanders K, Lewis SM, Maseri A. Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thromb Haemost 1988;59: 259–63.
   PubMedGoogle Scholar
• Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009:63:1509–15.
   PubMed Web of Science ®Google Scholar
• Boyaci A, Topaloglu S, Yilmaz S, Yanik O, Ozdemir O, Demir AD, Aras D, Kisacik H, Korkmaz S. Regional left atrial coagulation and fibrinolytic activities in patients with mitral stenosis. Jpn Heart J 2004;45:779–88.
   PubMedGoogle Scholar
• Zaki A, Salama M, El Masry M, Abou-Freikha M, Abou-Ammo D, Sweelum M, Mashhour E, Elhendy A. Immediate effect of balloon valvuloplasty on hemostatic changes in mitral stenosis. Am J Cardiol 2000;85:370–5.
   PubMedGoogle Scholar
• Ikeda U, Yamamoto K, Shimada K. Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation and cardiomyopathy. Clin Cardiol 1997;20:7–10.
   PubMedGoogle Scholar
• Kinoshita O, Yoshimi H, Nagata S, Ishikura F, Kimura K, Yamabe T, Takagaki K, Miyatake K, Omae T. Rapid increase in plasma endothelin concentrations during percutaneous balloon dilatation of the mitral valve in patients with mitral stenosis. Br Heart J 1993;69:322–6.
   Google Scholar
• Ileri M, Buyukasik Y, Ileri NS, Haznedaroglu IC, Goksel S, Kirazli S, Dundar S. Activation of blood coagulation in patients with mitral stenosis and sinus rhythm. Am J Cardiol 1998;81:795–7.
   PubMedGoogle Scholar
• Chiang CW, Lo SK, Ko YS, Cheng NJ, Lin PJ, Chang CH. Predictors of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med 1998;128: 885–9.
   Google Scholar
• Kataoka H, Yano S, Tamura A, Mikuriya Y. Hemostatic changes induced by percutaneous mitral valvuloplasty. Am Heart J 1993;125:777–82.
   Google Scholar